The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (6.12) EUR. With the latest stock price at 1.13 EUR, the upside of Cellectis SA based on DCF is -643.3%.
Based on the latest price of 1.13 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 643.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 9.1% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (37.13) - (3.68) | (6.12) |
| Upside | -3397.1% - -426.7% | -643.3% |